Short-Acting Beta-2 Agonists and Ipratropium Combined
This medication, marketed in Canada under the name Combivent®, combines a short-acting bronchodilator, salbutamol (i.e. Ventolin®), and an anticholinergic medication, Ipratropium (Atrovent®). Combivent® is prescribed mainly for chronic bronchitis and emphysema. People with chronic bronchitis or emphysema take it 4 times a day.
